PDL BioPharma, Inc. (NASDAQ:PDLI)
| CAPS Rating |
|
|---|---|
| Open | $6.45 |
| Previous Close | $6.49 |
| Daily Range | $6.35 - $6.48 |
| 52-Week Range | $4.66 - $6.70 |
| Market Cap | $893.29M |
| P/E Ratio | 7.70 |
| Dividend (Yield) | 0.60 (15.80%) |
| Volume | 1,330,455 |
| Average Daily Volume | 0 |
PDLI
VS S&P 500 (SPY)
How do you think PDLI will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PDLI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PDLI News and Commentary
- Make Money in Hefty-Dividend Payers the Easy Way – The Motley Fool
- 1 Great Dividend to Buy, 1 Weak Dividend to Sell – The Motley Fool
- Among 5 Small-Cap Dividend Dynamos, 1 Stands Out – The Motley Fool
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- Biotech Royalties, Almost as Good as Cash – The Motley Fool
- Don't Get Trapped by High Dividends - Analyst Blog – NASDAQ
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- Here's What 1 of the Best Investors Is Buying – The Motley Fool
- Alexion Looks Fine With These 2 Metrics – The Motley Fool
- Has PDL BioPharma Become the Perfect Stock? – The Motley Fool
- The Highest-Rated Biotech Stocks – The Motley Fool
- 5 Cheap Healthcare Dividend Stocks By PEG Ratio – Blog at The Motley Fool
- 14 Healthcare Dividend Stocks With Biggest Institutional Buys – Blog at The Motley Fool
- These Dividend Stocks Are Something Special – The Motley Fool
- Let's See If Alexion's Growth Is for Real – The Motley Fool
- PDL BioPharma’s Management Is Creating Value – The Motley Fool
- Here's What Seth Klarman Is Buying – The Motley Fool
- Ex-Dividend Stocks On September 6, 2011 – Blog at The Motley Fool
- The 25 Highest-Yielding Stocks – The Motley Fool
- Making Cents in Penny Stocks – The Motley Fool
RSS Headlines
Fool UK
